BioSpace News Archive

Bio NC

Contego Medical Announces the Start of Enrollment in the PERFORMANCE II Carotid Stenting Clinical Trial

Contego Medical, Inc. announced enrollment of the first patient in the PERFORMANCE II Trial evaluating the safety and effectiveness of the Neuroguard IEP® 3 in 1 Carotid Stent and Post-Dilation Balloon System with Integrated Embolic Protection.

June 15, 2020
·
3 min read
Biotech Beach

Otonomy Provides Update on Clinical Trials and Development Programs

Otonomy, Inc., a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, provided an update on its product pipeline and the timeline to results for the company’s three ongoing clinical trials, including the Phase 3 trial of OTIVIDEX in Ménière’s disease.

June 15, 2020
·
10 min read
Business

Adverum Biotechnologies Announces Leadership Transition

Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that Laurent Fischer, M.D. has joined the company as its chief executive officer and a member of the board of directors.

June 15, 2020
·
6 min read
Pharm Country

Celldex Therapeutics Announces Proposed Public Offering of Common Stock

Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX), today announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering.

June 15, 2020
·
5 min read
Biotech Beach

Endologix Issues Correction Notice for Ovation iX Abdominal Stent Graft System

Endologix® Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, today announced that a correction notice has been issued for the Ovation iX system, that identifies the root cause of polymer leaks.

June 15, 2020
·
6 min read
BioCapital

FDA Permits Marketing of First Game-Based Digital Therapeutic to Improve Attention Function in Children with ADHD

Today, the U.S. Food and Drug Administration (FDA) permitted marketing of the first game-based digital therapeutic device to improve attention function in children with attention deficit hyperactivity disorder (ADHD)

June 15, 2020
·
3 min read
Biotech Beach

Neurocrine Biosciences to Present at the Bank of America Securities 2020 Napa Biopharma Conference

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Bank of America Securities 2020 Napa Biopharma Conference at 2:00 p.m. PT (5:00 p.m. ET) on Monday, June 22, 2020. Kevin Gorman, Chief Executive Officer, will present at the conference.

June 15, 2020
·
1 min read
Policy

Patient Safety Authority Releases Actionable Insights for Pennsylvania Health Systems

The Patient Safety Authority has released its 2019 annual report, offering key insights to inspire change and improve patient safety in Pennsylvania and beyond.

June 15, 2020
·
2 min read
Business

Guardion Health Sciences Names Dr. David Evans as Interim President and Interim Chief Executive Officer

Guardion Health Sciences, Inc. announced that its Board of Directors has appointed Dr. David Evans, Ph.D. as the Company’s Interim President and Interim Chief Executive Officer effective immediately.

June 15, 2020
·
4 min read
Policy

Coronavirus (COVID-19) Update: FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of a COVID-19 Treatment Authorized for Emergency Use

The U.S. Food and Drug Administration is warning health care providers about a newly discovered potential drug interaction related to the investigational antiviral drug remdesivir, which has received emergency use authorization for the treatment of hospitalized COVID-19 patients with severe disease.

June 15, 2020
·
3 min read